Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 729-739.
Prepublished online as a Blood First Edition Paper on September 7, 2006; DOI 10.1182/blood-2006-04-015958.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-015958v1
109/2/729    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, A.
Right arrow Articles by Cerutti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, A.
Right arrow Articles by Cerutti, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 10, 2006
Accepted August 21, 2006

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

April Chiu, Weifeng Xu, Bing He, Stacey R. Dillon, Jane A. Gross, Eric Sievers, Xugang Qiao, Paul Santini, Elizabeth Hyjek, Joong-won Lee, Ethel Cesarman, Amy Chadburn, Daniel M Knowles, and Andrea Cerutti*

Dept. of Pathology & Laboratory Medicine of Weill Medical College of Cornell University, New York,NY
ZymoGenetics, Inc., Seattle, WA USA

* Corresponding author; email: acerutti{at}med.cornell.edu.

Hodgkin lymphoma (HL) originates from the clonal expansion of malignant Hodgkin and Reed Sternberg (HRS) cells. These B cell-derived elements constitute less than 10% of the tumoral mass. The remaining tissue is comprised of an inflammatory infiltrate that includes myeloid cells. Myeloid cells activate B cells by producing BAFF and APRIL, which engage TACI, BCMA and BAFF-R receptors on the B cells. Here we studied the role of BAFF and APRIL in HL. Inflammatory and HRS cells from HL tumors expressed BAFF and APRIL. Unlike their putative germinal center B cell precursors, HRS cells lacked BAFF-R, but expressed TACI and BCMA, a phenotype similar to that of plasmacytoid B cells. BAFF and APRIL enhanced HRS cell survival and proliferation by delivering non-redundant signals via TACI and BCMA receptors through both autocrine and paracrine pathways. These signals caused NF-{kappa}B activation, Bcl-2, Bcl-xL and c-Myc up-regulation, and Bax down-regulation and were amplified by APRIL-binding proteoglycans on HRS cells. Interruption of BAFF and APRIL signaling by TACI-Ig decoy receptor, which binds to and neutralizes BAFF and APRIL, or small interfering RNAs targeting BAFF, APRIL, TACI and BCMA inhibited HRS cell accumulation in vitro and might attenuate HL expansion in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020